COR Q1 2023 Earnings — Cencora, Inc. Revenue & Financial Results | Market Cap Arena

CORCencora, Inc.

$69B

Q1 2023 Earnings

Healthcare Medical - Distribution

Income Statement

Revenue

$62.8B+5.4% YoY

Gross Profit

$1.9B3.1% margin

Operating Income

$633M1.0% margin

Net Income

$480M0.8% margin

EPS (Diluted)

$2.33

QoQ Revenue Growth

+2.7%

Cash Flow

Operating Cash Flow

$710M

Free Cash Flow

$634M

Stock-Based Comp.

$56M

Balance Sheet

Total Assets

$57.9B

Total Liabilities

$57.8B

Stockholders' Equity

-$178M

Cash & Equivalents

$1.9B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$62.8B	$59.6B	+5.4%
Gross Profit	$1.9B	$1.9B	+2.1%
Operating Income	$633M	$714M	-11.4%
Net Income	$480M	$449M	+6.8%

Revenue Segments

Pharmaceutical Distribution

$55.1B88%

International Healthcare Solutions

$6.6B11%

Animal Health

$1.2B2%

Geographic Segments

U.S. Healthcare Solutions

$56.2B89%

International Healthcare Solutions

$6.6B11%